Send to

Choose Destination
J Med Chem. 2010 Aug 12;53(15):5422-38. doi: 10.1021/jm100076w.

Identification of potent and selective amidobipyridyl inhibitors of protein kinase D.

Author information

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.


The synthesis and biological evaluation of potent and selective PKD inhibitors are described herein. The compounds described in the present study selectively inhibit PKD among other putative HDAC kinases. The PKD inhibitors of the present study blunt phosphorylation and subsequent nuclear export of HDAC4/5 in response to diverse agonists. These compounds further establish the central role of PKD as an HDAC4/5 kinase and enhance the current understanding of cardiac myocyte signal transduction. The in vivo efficacy of a representative example compound on heart morphology is reported herein.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center